Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences, Inc. (RNA) Net Income (2019 - 2025)

Avidity Biosciences' Net Income history spans 7 years, with the latest figure at -$236.6 million for Q4 2025.

  • For Q4 2025, Net Income fell 130.95% year-over-year to -$236.6 million; the TTM value through Dec 2025 reached -$682.7 million, down 111.98%, while the annual FY2025 figure was -$682.7 million, 111.98% down from the prior year.
  • Net Income reached -$236.6 million in Q4 2025 per RNA's latest filing, down from -$174.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$23.8 million in Q1 2021 to a low of -$236.6 million in Q4 2025.
  • Average Net Income over 5 years is -$75.4 million, with a median of -$52.2 million recorded in 2023.
  • Peak YoY movement for Net Income: crashed 291.8% in 2021, then dropped 2.57% in 2023.
  • A 5-year view of Net Income shows it stood at -$38.5 million in 2021, then tumbled by 31.07% to -$50.5 million in 2022, then fell by 19.59% to -$60.3 million in 2023, then tumbled by 69.81% to -$102.5 million in 2024, then tumbled by 130.95% to -$236.6 million in 2025.
  • Per Business Quant, the three most recent readings for RNA's Net Income are -$236.6 million (Q4 2025), -$174.1 million (Q3 2025), and -$156.7 million (Q2 2025).